Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Japan / NCT06761508
Starting soon Not applicable

Comparing of Different Visual Aids Like Video,info-graphics and Pamphlets in Enhancing Community Awareness and Promoting Behavioral Change Towards the Prevention of Hypertension in Basilica of the Most Holy Trinity Onitsha Anambra State,Nigeria

NCT06761508 · tracked via the Priya Life Science Japan tracker
Sponsor
Hiroshima University
Phase
Not applicable
Started
2025-01-05
Last updated
2025-01-07

Condition(s) studied

Hypertension

Investigational drug(s) / intervention(s)

Intervention study for Arm one using videointervention 2:using infographicsintervention 3: use of pamphlet

Intervention study for Arm one using video: A 3 Arm randomized control trial, using video as the first Arm of intervention to assess the behaviour change of the community in hypertension prevention.

intervention 2:using infographics: A 3 Arm randomized control trial,that involves the use of infographics in Arm to assess the behaviour change of the community in hypertension prevention.

intervention 3: use of pamphlet: A 3 Arm randomized control trial,that contains the use of pamphlet for the 3rd Arm which is the control group to assess the behaviour change of the community in hypertension prevention.

Study summary

The goal of this observational study is to assess different level of enhanced awareness and behavioral change of adults over the age of 35 who will be educated using video,infographic and pamphlet for the interval of one month

Eligibility

Sex
ALL
Min age
35 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults age over 35 years old * Who does not know his/her blood pressure status within the last 6 months (The person who does not know he or she has a hypertension or not.) * Who agree to participate Exclusion Criteria: * Who cannot come to the church 4 weeks later after the intervention. * Known hypertensive patients

Primary outcome measure(s)

  • Behavioural change in hypertension prevetion — One month
    Behaviour changes within 1 month related to education \- Asking what kind of behaviour change occurred during 1 month Percentage caculation of participants who had behaviour change Each arm: Number of person who changed their behaviour/total number of participants in the arm

Trial sites (1)

FacilityCityRegionStatus
Graduate School of Biomedical and Health Sciences Hiroshima University Kasumi 1-2-3 Minami-ku Japan

More Hiroshima University trials in Japan

International Survey for EXTubation Evaluation and Respiratory Dynamics in Acute Respiratory Distress Syndrome Enrolling by invitation
Effect of Implementing Evidence-based Practice and Nurse's Behavior Change on Quality of Care in Intensive Care Unit: Focus on Ventilator Associated Pneumonia in a Tertiary Hospital in Bangladesh Recruiting
Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central Line Bloodstream Infection in Intensive Care Unit in Bangladesh Starting soon

Other trials for the same condition

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease Recruiting
Effect of Dotinurad in Hyperuricemia With Hypertension Recruiting
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 Recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients Active, not recruiting
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06761508 on ClinicalTrials.gov ↗ ← All trials in Japan